RADAR-CNS
Verified IntelRemote Assessment of Disease and Relapse – Central Nervous System (RADAR-CNS) is an international research programme exploring the potential of wearable devices to help prevent and treat depression, multiple sclerosis and epilepsy. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115902. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. See www.imi.europa.eu for more details.
Remote Assessment of Disease and Relapse – Central Nervous System (RADAR-CNS) is an international research programme exploring the potential of wearable devices to help prevent and treat depression, multiple sclerosis and epilepsy. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115902. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. See www.imi.europa.eu for more details.
Corporate Firmographics
Entity classification and operating profile
- Industry
- Research
- Company Type
- Nonprofit
- Founded
- Undisclosed
- Employee Bracket
- 1-10
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- 16 De Crespigny Park England London
- City
- —
- Region / State
- —
- Postal Code
- SE5 8
- Country
- United Kingdom
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for RADAR-CNS.